信越控股(06038.HK)2020年淨利2329.9萬港元 同比減少11.63%
格隆匯 3 月 31日丨信越控股(06038.HK)公佈,截至2020年12月31日止年度,公司收益2.43億港元,同比減少18.80%;期間溢利2329.9萬港元,同比減少11.63%;每股盈利2.3港仙,末期股息每股1.1港仙。
收益減少主要由於在集團工程動工前的階段,其他承建商延遲施工,導致一個主要項目的進度延遲。於2020年度,在設計和建造項目收益中,來自平台外牆及相關工程的收益及來自幕牆工程的收益分別為68.5%及31.5%,而於2019年度則各佔50.0%,此乃由於大部分重點幕牆工程已於2019年度竣工,且本集團於2020年度並無承接新的幕牆工程。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.